Pfizer Keeps Market Guessing On M&A Moves As Earnings Rise
Pfizer Inc. said Tuesday that strong performance from its cancer drugs and in emerging markets have pushed its third-quarter earnings above expectations, but did not hint at any major M&A plays...To view the full article, register now.
Already a subscriber? Click here to view full article